1. Home
  2. ACXP vs SPCB Comparison

ACXP vs SPCB Comparison

Compare ACXP & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • SPCB
  • Stock Information
  • Founded
  • ACXP 2017
  • SPCB 1988
  • Country
  • ACXP United States
  • SPCB Israel
  • Employees
  • ACXP N/A
  • SPCB N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • SPCB Semiconductors
  • Sector
  • ACXP Health Care
  • SPCB Technology
  • Exchange
  • ACXP Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • ACXP 8.4M
  • SPCB 53.3M
  • IPO Year
  • ACXP 2021
  • SPCB N/A
  • Fundamental
  • Price
  • ACXP $0.45
  • SPCB $10.11
  • Analyst Decision
  • ACXP Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • ACXP 2
  • SPCB 1
  • Target Price
  • ACXP $10.00
  • SPCB $18.00
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • SPCB 133.1K
  • Earning Date
  • ACXP 08-08-2025
  • SPCB 08-14-2025
  • Dividend Yield
  • ACXP N/A
  • SPCB N/A
  • EPS Growth
  • ACXP N/A
  • SPCB N/A
  • EPS
  • ACXP N/A
  • SPCB 1.89
  • Revenue
  • ACXP N/A
  • SPCB $27,831,000.00
  • Revenue This Year
  • ACXP N/A
  • SPCB $2.73
  • Revenue Next Year
  • ACXP N/A
  • SPCB $22.87
  • P/E Ratio
  • ACXP N/A
  • SPCB $5.56
  • Revenue Growth
  • ACXP N/A
  • SPCB 2.90
  • 52 Week Low
  • ACXP $0.30
  • SPCB $2.55
  • 52 Week High
  • ACXP $3.33
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 52.38
  • SPCB 52.51
  • Support Level
  • ACXP $0.45
  • SPCB $9.23
  • Resistance Level
  • ACXP $0.59
  • SPCB $11.00
  • Average True Range (ATR)
  • ACXP 0.08
  • SPCB 0.59
  • MACD
  • ACXP -0.01
  • SPCB -0.08
  • Stochastic Oscillator
  • ACXP 27.06
  • SPCB 56.15

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: